Results 61 to 70 of about 1,242,031 (332)

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Clinical Infectious Diseases, 2020
Background The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) first broke out in Wuhan (China) and subsequently spread worldwide. Chloroquine has been sporadically used in treating SARS-CoV-2 infection.
Xueting Yao, F. Ye, Miao Zhang, Cheng Cui, Baoying Huang, P. Niu, X. Liu, Li Zhao, Erdan Dong, Chunli Song, S. Zhan, R. Lu, Haiyan Li, W. Tan, Dongyang Liu   +14 more
semanticscholar   +1 more source

Survival and disinfection of SARS-Cov-2 in environment and contaminated surface [PDF]

, 2020
The detection of SARS-Cov-2 in the sewage and water resources has increased the awareness among the people about the possibility survival of SARS-Cov-2 in the environment and the potential to transmit into the human through food chain or water resources.
Al-Gheethi, Adel, Al-Maqtari, Qais, Almoheer, Reyad, Hamdan, Rafidah, Noman, Efaq, Radin Mohamed, Radin Maya Saphira   +5 more
core  

COVID-19 publications: Database coverage, citations, readers, tweets, news, Facebook walls, Reddit posts [PDF]

, 2020
© 2020 The Authors. Published by MIT Press. This is an open access article available under a Creative Commons licence. The published version can be accessed at the following link on the publisher’s website: https://doi.org/10.1162/qss_a_00066The COVID ...
Adie E., Chen Q., Clark F., Colavizza G., Costas R., de Solla Price D., Delwiche F. A., Fairclough R., Gunn W., Harzing A. W., Haustein S., Haustein S., Haustein S., Holmberg K., Ioannidis J. P., Kostoff R. N., Kousha K., Kousha K., Lewison G., Merchant R. M., Mohammadi E., Mohammadi E., Mohammadi E., Mohammadi E., Mohammadi E., Orduña-Malea E., Ortega J. L., Ortega J. L., Ovadia S., Pouris A., Pouris A., Rethlefsen M. L., Robinson-García N., Robinson-García N., Song P., Stegehuis C., Stoddard G., Sud P., Thelwall M., Thelwall M., Thelwall M., Thelwall M., Thelwall M., Thelwall M., Thelwall M., Thelwall M., Tian D., Torres-Salinas D., Van Noorden R., Wallace M. L., WHO, Yu H., Zahedi Z., Zahedi Z., Zahedi Z.   +54 more
core   +2 more sources

SARS CoV- 2 vaccination induces antibodies against cardiolipin

BMC Research Notes, 2022
Objective Cases of thrombosis have been reported after administration of SARS-CoV-2 vaccines, with controversial results relating to Oxford-AstraZeneca’s ChAdOx1-S.
George Krashias, Anna Pafiti, Elie Deeba, Christina Christodoulou, Marios Pantzaris, Anastasia Lambrianides   +5 more
doaj   +1 more source

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

Nature Microbiology, 2020
Over the past 20 years, several coronaviruses have crossed the species barrier into humans, causing outbreaks of severe, and often fatal, respiratory illness. Since SARS-CoV was first identified in animal markets, global viromics projects have discovered
M. Letko, A. Marzi, V. Munster
semanticscholar   +1 more source

Brief Summary of Potential SARS-CoV-2 Prophylactic and Treatment Drugs in the Emergency Department [PDF]

, 2020
As of March 30th, 2020 there were 161,807 total cases and 2,953 total deaths of SARS-CoV-2 in the United States, with the number of cases expected to rise.
Brown, Cortlyn, Coralic, Zlatan, Noble, Jeanne   +2 more
core  

Droplet evaporation residue indicating SARS-COV-2 survivability on surfaces

, 2020
SARS-CoV-2 survives and remains viable on surfaces for several days under different environments as reported in recent studies. However, it is unclear how the viruses survive for such a long time and why their survivability varies across different ...
He, Zilong, Hong, Jiarong, Kumar, S. Santosh, Li, Jiaqi, Shao, Siyao, Sokoloff, J. B.   +5 more
core   +1 more source

The pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses [PDF]

, 2020
We are proposing the use of pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses. The designed strategy represents a potential treatment to reduce the overall viral load in the lungs and to help the immune system to successfully stave
Feliciello, Isidoro, Procino, Alfredo
core   +1 more source

SARS‐CoV‐2 Omicron variant: Characteristics and prevention

MedComm, 2021
Coronavirus disease 2019 (COVID‐19) has brought about a great threat to global public health. Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variant B.1.1.529 has been reported in South Africa and induced a rapid increase in
Xuemei He, Weiqi Hong, Xiangyu Pan, Guangwen Lu, Xiawei Wei   +4 more
doaj   +1 more source

Cell entry mechanisms of SARS-CoV-2

Proceedings of the National Academy of Sciences of the United States of America, 2020
Significance A key to curbing SARS-CoV-2 is to understand how it enters cells. SARS-CoV-2 and SARS-CoV both use human ACE2 as entry receptor and human proteases as entry activators.
J. Shang, Yushun Wan, C. Luo, G. Ye, Q. Geng, Ashley A. Auerbach, Fang Li   +6 more
semanticscholar   +1 more source